APC
EXAS

Aspire Private Capital’s Exact Sciences EXAS Stock Holding History

Aspire Private Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-93
Closed -$11K – 485
2019
Q2 		$11K Buy
93
+18
+24% +$1.81K 0.01% 259
2019
Q1 		$6K Sell
75
-5
-6% -$426 ﹤0.01% 346
2018
Q4 		$5K Buy
+80
New +$5.49K ﹤0.01% 342

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Aspire Private Capital's EXAS Position: Q3 2019 in Review

Aspire Private Capital sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 93 shares — an estimated $11K sold.

Aspire Private Capital first reported a position in EXAS in Q4 2018 and held it in 3 quarters. The position peaked at $11K in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Aspire Private Capital reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
  • Aspire Private Capital sold 93 Exact Sciences shares in Q3 2019, an estimated $11K.
  • Aspire Private Capital first reported a position in Exact Sciences in Q4 2018 and held it in 3 quarters.
  • Aspire Private Capital's Exact Sciences position peaked at $11K in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Aspire Private Capital's 13F filing for Q3 2019, filed 12 Nov 2019.